Muutke küpsiste eelistusi

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance, Volume 172 [Kõva köide]

4.00/5 (2 hinnangut Goodreads-ist)
Edited by (University of Malta, Malta), Edited by (Istituto di Ricerche Farmacologiche Mario Negri, Italy), Edited by (Istituto di Ricerche Farmacologiche Mario Negri, Italy)
  • Formaat: Hardback, 688 pages, kõrgus x laius: 244x175 mm, kaal: 1800 g
  • Sari: Progress in Brain Research
  • Ilmumisaeg: 26-Sep-2008
  • Kirjastus: Elsevier Science Ltd
  • ISBN-10: 0444532358
  • ISBN-13: 9780444532350
Teised raamatud teemal:
Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance, Volume 172Suurem pilt
  • Formaat: Hardback, 688 pages, kõrgus x laius: 244x175 mm, kaal: 1800 g
  • Sari: Progress in Brain Research
  • Ilmumisaeg: 26-Sep-2008
  • Kirjastus: Elsevier Science Ltd
  • ISBN-10: 0444532358
  • ISBN-13: 9780444532350
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9780444532350.html
Märksõnad:
This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the serotonin (5-HT)-dopamine (DA) interactions. Central serotonergic and dopaminergic systems play a critical role in the regulation of normal and abnormal behaviors. Moreover, recent evidence suggests that the dysfunction of the DA and 5-HT neurotransmitter systems contribute to various mental disorders including depression, schizophrenia, drug addiction and Parkinson’s disease. This extremely important topic is of wide interest within the scientific community, with relevance not only to specialists but also to general practitioners and students. The book provides a valuable contribution to the debate on new pharmacological approaches for several psychopathological states, with contributions from expert neuroscientists and pharmacologists who comprehensively survey the most significant currently active areas of dopamine/serotonin interactions.

* Provides an understanding of the interaction between Serotonin and Dopamine.
* Appeals equally to specialists, general practitioners, students and researchers.
* Contributes to the debate on new pharmacological approaches to several psychopathological states
* Gives a comprehensive anatomical description plus the physiology and pharmacology of dopaminergic and serotonergic systems
* Singles out neuropsychiatric and suggests new therapeutic approaches.
List of contributors
v
Preface ix
Dedication xi
Serotonin-Dopamine Interactions in the Central Nervous System
Serotonin-dopamine interaction: an overview
3(4)
E. Esposito
V. Di Matteo
G. Di Giovanni
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies
7(38)
V. Di Matteo
G. Di Giovanni
M. Pierucci
E. Esposito
Serotonin-dopamine interaction: electrophysiological evidence
45(28)
G. Di Giovanni
V. Di Matteo
M. Pierucci
E. Esposito
Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders
73(28)
U.M. D'Souza
I.W. Craig
Serotonin-Dopamine Interactions in Schizophrenia
Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment
101(16)
J. de Almeida
J.M. Palacios
G. Mengod
Alterations of dopamine and serotonin transmission in schizophrenia
117(24)
G. Remington
Serotonin and dopamine interactions in psychosis prevention
141(14)
N.M. Richtand
R.K. McNamara
Role of serotonin and dopamine receptor binding in antipsychotic efficacy
155(22)
N.M. Richtand
J.A. Welge
A.D. Logue
P.E. Keck Jr.
S.M. Strakowski
R.K. McNamara
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems
177(22)
H.Y. Meltzer
M. Huang
Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis
199(14)
T. Kuroki
N. Nagao
T. Nakahara
Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders
213(20)
M.D. Wood
P.W. Wren
Serotonin-Dopamine Interactions in Depression
The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease
233(32)
K.A. Michelsen
J. Prickaerts
H.W.M. Steinbusch
Dynamics of the dopaminergic system as a key component to the understanding of depression
265(22)
G. Yadid
A. Friedman
Physiological and therapeutic relevance of constitutive activity of 5-HT2A and 5-HT2c receptors for the treatment of depression
287(20)
K.A. Berg
J.A. Harvey
U. Spampinato
W.P. Clarke
The role of dopamine and serotonin in suicidal behaviour and aggression
307(12)
E. Ryding
M. Lindstrom
L. Traskman-Bendz
Serotonin-Dopamine Interactions in Drug Addiction
Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse
319(28)
M.J. Bubar
K.A. Cunningham
Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour
347(14)
R.J. Carey
J.P. Huston
C.P. Muller
Serotonin receptors as potential targets for modulation of nicotine use and dependence
361(24)
P.J. Fletcher
A. Dzung Le
G.A. Higgins
Dopamine/serotonin releasers as medications for stimulant addictions
385(22)
R.B. Rothman
B.E. Blough
M.H. Baumann
PTEN-5-HT2C coupling: a new target for treating drug addiction
407(16)
J.-C. Maillet
Y. Zhang
X. Li
X. Zhang
Scrotonin-Dopamine Interactions in Motor Disorders
Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders
423(42)
V. Di Matteo
M. Pierucci
E. Esposito
G. Crescimanno
A. Benigno
G. Di Giovanni
Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias
465(14)
M. Carta
T. Carlsson
A. Munoz
D. Kirik
A. Bjorklund
Parkinson's disease --- opportunities for novel therapeutics to reduce the problems of levodopa therapy
479(16)
S.H. Fox
R. Chuang
J.M. Brotchie
Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome
495(22)
T.D.L. Steeves
S.H. Fox
Serotonin-Dopamine Interactions in Attentional Processes, Learning and Memory
Serotonergic and dopaminergic modulation of attentional processes
517(26)
V. Boulougouris
E. Tsaltas
Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD)
543(24)
R.D. Oades
Serotonin/dopamine interaction in learning
567(36)
M.E. Olvera-Cortes
P. Anguiano-Rodriguez
M.A. Lopez-Vazquez
J.M.C. Alfaro
Serotonin/dopamine interaction in memory formation
603(22)
I. Gonzalez-Burgos
A. Feria-Velasco
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking
625(22)
J.M. Monti
H. Jantos
Subject Index 647
Prof. Giuseppe Di Giovanni received his Ph.D. in Neuroscience from the University of Chieti, Italy and was a postdoctoral fellow at Yale University, USA. Previously Senior Lecturer of Human Physiology at the Faculty of Medicine and Surgery, University of Palermo, and Associate Professor at the University of Malta, from 2013 he is Professor of Human Physiology at the Medical School of the University of Malta and from 2018 Honorary Professor at Cardiff University, UK. His research focuses on understanding the pathophysiology of monoaminergic systems using electrophysiological and neurochemical approach. He has published more than 120 peer-reviewed papers, edited 7 books and 6 special issues of various journals.